Literature DB >> 7768342

Cognitive function and academic performance in children with neurofibromatosis type 1.

K North1, P Joy, D Yuille, N Cocks, P Hutchins.   

Abstract

The authors evaluated 51 consecutive children with NF1 (aged eight to 16 years) to determine the frequency of intelectual impairment and learning disability due to NF1 alone, the profile of learning disabilities and the effect of clinical variables. 40 children completed the full assessment protocol. There was no support for a profile of predominantly visuoperceptual deficits in the NF1 population. There was no discrepancy between verbal and performance IQ, and the deficits in function were wide ranging. Clinical variables such as age, sex, socio-economic status, disease severity, macrocephaly and family history of NF1 were not associated with cognitive deficits. These results emphasise the need for developmental evaluation to be included in the routine assessment of children with NF1.

Entities:  

Mesh:

Year:  1995        PMID: 7768342     DOI: 10.1111/j.1469-8749.1995.tb12026.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  20 in total

1.  A child with axillary freckling and café au lait spots.

Authors:  Stephen Wainer
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

2.  Neurocognitive deficits in children with neurofibromatosis type 1.

Authors:  Roger J Packer
Journal:  Curr Neurol Neurosci Rep       Date:  2006-03       Impact factor: 5.081

3.  Teaching reading to children with neurofibromatosis type 1: a clinical trial with random assignment to different approaches.

Authors:  Laura A Barquero; Angela M Sefcik; Laurie E Cutting; Sheryl L Rimrodt
Journal:  Dev Med Child Neurol       Date:  2015-04-22       Impact factor: 5.449

4.  Psychological aspects of von Recklinghausen neurofibromatosis (NF1)

Authors:  K N North
Journal:  J Med Genet       Date:  1996-09       Impact factor: 6.318

Review 5.  Alternative splicing of the neurofibromatosis type I pre-mRNA.

Authors:  Victoria A Barron; Hua Lou
Journal:  Biosci Rep       Date:  2012-04-01       Impact factor: 3.840

6.  Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.

Authors:  Jacquelyn A Brown; Kelly A Diggs-Andrews; Scott M Gianino; David H Gutmann
Journal:  Mol Cell Neurosci       Date:  2011-08-26       Impact factor: 4.314

Review 7.  Neurocognitive dysfunction in children with neurofibromatosis type 1.

Authors:  Tena L Rosser; Roger J Packer
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

8.  Visuospatial processing in children with neurofibromatosis type 1.

Authors:  Amy M Clements-Stephens; Sheryl L Rimrodt; Pooja Gaur; Laurie E Cutting
Journal:  Neuropsychologia       Date:  2007-10-02       Impact factor: 3.139

Review 9.  Familial syndromes associated with intracranial tumours: a review.

Authors:  Adrianna M Ranger; Yatri K Patel; Navjot Chaudhary; Ram V Anantha
Journal:  Childs Nerv Syst       Date:  2013-11-06       Impact factor: 1.475

10.  Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor.

Authors:  T A Rizvi; S Akunuru; G de Courten-Myers; R C Switzer; M L Nordlund; N Ratner
Journal:  Brain Res       Date:  1999-01-16       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.